The biodefense products market is expected to grow in the coming years


Market research firm Graphical Research has published an analysis indicating that the size of the global biodefense market is expected to increase significantly through 2028.

The group identified the growing incidence of infectious diseases and bioterrorism activities as central to this forecast, with several countries increasing production of biodefense products in response.

The concept of biodefense includes a range of interventions, such as drugs and vaccines,…

This article is accessible to registered users, to continue reading, please register for free. A free trial will give you access to exclusive features, interviews, summaries and commentary from the sharpest minds in the pharma and biotech space for one week. If you are already a registered user, please login. If your trial period is over, you can register here.

Try before you buy

• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analysis and commentary from our global network of life science journalists.
• Receive The Pharma Letter daily newsletter, free forever.

Become a subscriber

• Unfettered access to top pharmaceutical and biotechnology industry news, commentary and analysis.
• Updates on clinical trials, conferences, mergers and acquisitions, licensing, financing, regulatory, patent and legal, executive appointments, business strategy and financial results.
• Daily roundup of key events in pharma and biotechnology.
• In-depth monthly briefings on board appointments and M&A news.
• Choose between an economical annual plan or a flexible monthly subscription.


Comments are closed.